A Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER in Children With Pain

NCT01586494 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: ULTRAM ER
DRUG: ULTRAM ER

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.